Moussa M - Search Results

1

Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer.

Chin JL, Ng CK, Touma NJ, Pus NJ, Hardie R, Abdelhady M, Rodrigues G, Radwan J, Venkatesan V, Moussa M, Downey DB, Bauman G. Chin JL, et al. Among authors: moussa m. Prostate Cancer Prostatic Dis. 2008;11(1):40-5. doi: 10.1038/sj.pcan.4500988. Epub 2007 Jun 19. Prostate Cancer Prostatic Dis. 2008. PMID: 17579613 Clinical Trial.

2

The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer.

Chan SM, Garcia FJ, Chin JL, Moussa M, Gabril MY. Chan SM, et al. Among authors: moussa m. Prostate Cancer Prostatic Dis. 2011 Dec;14(4):307-12. doi: 10.1038/pcan.2011.15. Epub 2011 Apr 19. Prostate Cancer Prostatic Dis. 2011. PMID: 21502968

3

PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.

Imasato Y, Xuan JW, Sakai H, Izawa JI, Saito Y, Chin JL, Moussa M. Imasato Y, et al. Among authors: moussa m. J Urol. 2000 Nov;164(5):1819-24. J Urol. 2000. PMID: 11025776

4

Metallothionein expression in renal cancer.

Izawa JI, Moussa M, Cherian MG, Doig G, Chin JL. Izawa JI, et al. Among authors: moussa m. Urology. 1998 Nov;52(5):767-72. doi: 10.1016/s0090-4295(98)00323-9. Urology. 1998. PMID: 9801096

5

DNA cytometric proliferative index predicting organ confinement in clinical stage-B prostate cancer.

Moussa M, Song TY, Frei JV, Peers G, Chin JL. Moussa M, et al. Clin Invest Med. 1997 Apr;20(2):119-26. Clin Invest Med. 1997. PMID: 9088668

6

Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.

Moussa M, Kloth D, Peers G, Cherian MG, Frei JV, Chin JL. Moussa M, et al. Clin Invest Med. 1997 Dec;20(6):371-80. Clin Invest Med. 1997. PMID: 9413634

7

Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.

Gabril MY, Onita T, Ji PG, Sakai H, Chan FL, Koropatnick J, Chin JL, Moussa M, Xuan JW. Gabril MY, et al. Among authors: moussa m. Gene Ther. 2002 Dec;9(23):1589-99. doi: 10.1038/sj.gt.3301895. Gene Ther. 2002. PMID: 12424611

8

3D prostate histology reconstruction: an evaluation of image-based and fiducial-based algorithms.

Gibson E, Gaed M, Gómez JA, Moussa M, Romagnoli C, Pautler S, Chin JL, Crukley C, Bauman GS, Fenster A, Ward AD. Gibson E, et al. Among authors: moussa m. Med Phys. 2013 Sep;40(9):093501. doi: 10.1118/1.4816946. Med Phys. 2013. PMID: 24007184

9

Rodent PSP94 gene expression is more specific to the dorsolateral prostate and less sensitive to androgen ablation than probasin.

Imasato Y, Onita T, Moussa M, Sakai H, Chan FL, Koropatnick J, Chin JL, Xuan JW. Imasato Y, et al. Among authors: moussa m. Endocrinology. 2001 May;142(5):2138-46. doi: 10.1210/endo.142.5.8181. Endocrinology. 2001. PMID: 11316782

10

Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.

Klotz L, Pond G, Loblaw A, Sugar L, Moussa M, Berman D, Van der Kwast T, Vesprini D, Milot L, Kebabdjian M, Fleshner N, Ghai S, Chin J, Haider M. Klotz L, et al. Among authors: moussa m. Eur Urol. 2020 Mar;77(3):311-317. doi: 10.1016/j.eururo.2019.10.007. Epub 2019 Nov 8. Eur Urol. 2020. PMID: 31708295 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,142 results

Search Page

Filters